MarketCap
Facebook
X
TelegramQuarterly report 2022-Q4
added 02-09-2023
Quotient Limited Operating Cash Flow 2011-2026 | QTNT
Annual Operating Cash Flow Quotient Limited
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| -77.6 M | -80.6 M | -75.7 M | -68.4 M | -56.2 M | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -56.2 M | -80.6 M | -71.7 M |
Quarterly Operating Cash Flow Quotient Limited
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | -89.2 M | -64.3 M | - | - | -96.2 M | -58.7 M | -32.1 M | - | -56.7 M | -30.6 M | -24.8 M | - | -64.8 M | -42.7 M | -25.1 M | - | -61.5 M | -41.1 M | - | - | - | -19.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -19.1 M | -96.2 M | -50.5 M |
Operating Cash Flow of other stocks in the Diagnostics research industry
| Issuer | Operating Cash Flow | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Agilent Technologies
A
|
1.48 B | $ 110.24 | -2.87 % | $ 33.5 B |  USA |
 |
Centogene N.V.
CNTG
|
-21.7 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Enzo Biochem
ENZ
|
-26.3 M | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
491 M | - | - | $ 19.8 B | USA |
|
Akumin
AKU
|
65.4 M | - | -17.87 % | $ 25.9 M |  Canada |
|
Biodesix
BDSX
|
-48.6 M | $ 14.21 | -2.67 % | $ 1.84 B | USA |
 |
Biomerica
BMRA
|
-3.84 M | $ 2.01 | -4.74 % | $ 4.62 M | USA |
 |
Burning Rock Biotech Limited
BNR
|
-478 M | $ 16.36 | -11.57 % | $ 176 M |  China |
 |
Sotera Health Company
SHC
|
287 M | $ 13.13 | -3.03 % | $ 3.73 B | USA |
 |
Brainsway Ltd.
BWAY
|
884 K | $ 12.87 | -4.6 % | $ 99.4 M |  Israel |
 |
Celcuity
CELC
|
-153 M | $ 106.02 | -7.66 % | $ 4.96 B | USA |
 |
Check-Cap Ltd.
CHEK
|
-8 M | - | - | $ 9.42 M | Israel |
 |
DarioHealth Corp.
DRIO
|
-25.9 M | $ 8.11 | -4.02 % | $ 32.3 M | Israel |
 |
Heska Corporation
HSKA
|
-21.8 M | - | - | $ 1.31 B | USA |
 |
BioNano Genomics
BNGO
|
-16.3 M | $ 1.16 | 0.87 % | $ 6.32 M | USA |
 |
DermTech
DMTK
|
-77 M | - | -11.32 % | $ 2.94 M | USA |
 |
Aspira Women's Health
AWH
|
-32.2 M | - | -6.19 % | $ 10.5 M | USA |
 |
DexCom
DXCM
|
1.44 B | $ 62.25 | -5.81 % | $ 24.3 B | USA |
 |
Accelerate Diagnostics
AXDX
|
-48.7 M | - | -61.36 % | $ 2.46 M | USA |
 |
Global Cord Blood Corporation
CO
|
614 M | - | - | $ 399 M | China |
 |
Genetic Technologies Limited
GENE
|
-5.66 M | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-524 M | - | 0.12 % | $ 80.1 M | China |
 |
HTG Molecular Diagnostics
HTGM
|
-18.4 M | - | -20.0 % | $ 1.06 M | USA |
 |
Castle Biosciences
CSTL
|
64.9 M | $ 23.53 | -4.74 % | $ 654 M | USA |
 |
Charles River Laboratories International
CRL
|
738 M | $ 159.16 | -3.62 % | $ 7.89 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
1.89 B | $ 195.51 | -1.22 % | $ 21.7 B | USA |
 |
Organovo Holdings
ONVO
|
-9.46 M | - | -2.3 % | $ 19.4 M | USA |
 |
OpGen
OPGN
|
-4.87 M | - | -16.95 % | $ 1.54 M | USA |
 |
Guardant Health
GH
|
-185 M | $ 84.61 | -3.96 % | $ 10.6 B | USA |
 |
Biocept
BIOC
|
-13.3 M | - | -13.05 % | $ 7.29 M | USA |
 |
ICON Public Limited Company
ICLR
|
1.29 B | $ 102.08 | -0.97 % | $ 8.42 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
1.18 B | $ 558.32 | -2.61 % | $ 44.9 B | USA |
 |
Illumina
ILMN
|
837 M | $ 117.67 | -5.41 % | $ 18.7 B | USA |
 |
PerkinElmer
PKI
|
583 M | - | -0.91 % | $ 14.7 B | USA |
 |
Invitae Corporation
NVTA
|
-493 M | - | - | $ 21.2 M | USA |
 |
IQVIA Holdings
IQV
|
2.65 B | $ 163.85 | -3.28 % | $ 28.2 B | USA |
 |
Interpace Biosciences
IDXG
|
4.65 M | $ 1.68 | -2.89 % | $ 7.37 M | USA |
 |
Motus GI Holdings
MOTS
|
-11.2 M | - | -34.28 % | $ 263 K | Israel |
 |
QIAGEN N.V.
QGEN
|
674 M | - | - | $ 10.6 B |  Niderland |
 |
Neogen Corporation
NEOG
|
58.2 M | $ 8.7 | -4.92 % | $ 1.89 B | USA |
 |
Chembio Diagnostics
CEMI
|
-12.7 M | - | 0.22 % | $ 16.8 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
1.64 B | $ 264.2 | -1.56 % | $ 22 B | USA |
 |
Psychemedics Corporation
PMD
|
-1.48 M | - | -1.84 % | $ 15.3 M | USA |
 |
Precipio
PRPO
|
-3.56 M | $ 25.97 | -4.52 % | $ 33.7 M | USA |
 |
CareDx, Inc
CDNA
|
42 M | $ 16.78 | -3.95 % | $ 894 M | USA |
 |
Syneos Health
SYNH
|
450 M | - | - | $ 4.46 B | USA |